- Report
- September 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- March 2025
- 50 Pages
Global
From €2531EUR$2,650USD£2,116GBP
Clidinium is a medication used to treat gastrointestinal disorders, such as irritable bowel syndrome and peptic ulcers. It is a muscarinic antagonist, meaning it blocks the action of the neurotransmitter acetylcholine in the smooth muscle of the gastrointestinal tract. This helps to reduce spasms and cramping, allowing the digestive system to function more normally. Clidinium is available in both capsule and tablet form, and is usually taken twice a day.
Clidinium is a popular choice for treating gastrointestinal disorders, as it is generally well-tolerated and has few side effects. It is also relatively inexpensive, making it an attractive option for those on a budget.
The clidinium market is highly competitive, with many pharmaceutical companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and GlaxoSmithKline. Other companies, such as Mylan and Teva, also offer generic versions of the drug. Show Less Read more